Neovasc Medical INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$601Kgeneral payments (2019-2025)
$6,500research payments (2019-2025)
50clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $110K
2020 $174K
2021 $149K
2022 $130K
2023 $38K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Cardiovascular Disease $308K
Interventional Cardiology $269K
Internal Medicine $6,960
Undersea and Hyperbaric Medicine (Emergency Medicine) $5,198

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Timothy Henry Cincinnati, OH Interventional Cardiology $255,745.30
Gregg Stone New York, NY Cardiovascular Disease $255,745.30
Sanjay Kaul Los Angeles, CA $12,000.00
Megha Prasad New York, NY Cardiovascular Disease $11,928.60
Frederic Resnic Burlington, MA Interventional Cardiology $10,200.00
Darren Mcguire Dallas, TX Cardiovascular Disease $9,100.00
Abraham Lincoff Cleveland, OH Cardiovascular Disease $7,425.00
John Teerlink San Francisco, CA Internal Medicine $6,750.00
Marvin Konstam Boston, MA Cardiovascular Disease $6,000.00
Richard Hopkins Shawnee Mission, KS Undersea and Hyperbaric Medicine (Emergency Medicine) $5,197.50

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.